Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Etiology of Hypertension and Endothelial Damage in Patients With Cytochrome P450 Oxidoreductase Deficiency

NCT06756620 is registered in ClinicalTrials.gov with Ozge Bayrak Demirel as lead sponsor.

NCT NCT06756620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06756620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Etiology of Hypertension and Endothelial Damage in Patients With Cytochrome P450 Oxidoreductase Deficiency
Lead sponsor
Ozge Bayrak Demirel
Phase
Observational
Overall status
Completed
Start date
December 24, 2024
Completion date
August 12, 2025
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital adrenal hyperplasia, cytochrome p450 oxidoreductase deficiency, endothelial dysfunction, hypertension